Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

New Orphan Drug Guidance Disappoints Small EU Firms

Sep. 8, 2004

By Peter O'Donnell

New Orphan Drug Guidance Disappoints Small EU Firms

Sep. 8, 2004

By Peter O'Donnell

New Faces Constructing New EU Biotechnology Guidelines

Aug. 18, 2004

By Peter O'Donnell

New Faces Constructing New EU Biotechnology Guidelines

Aug. 18, 2004

By Peter O'Donnell

EU Looking Ahead To Better Conditions For Biotech Sector

Aug. 4, 2004

By Peter O'Donnell

EU Looking Ahead To Better Conditions For Biotech Sector

Aug. 4, 2004

By Peter O'Donnell

After Much Debate, Monsanto's GM Maize Receives EU Approval

July 21, 2004

By Peter O'Donnell

After Much Debate, Monsanto's GM Maize Receives EU Approval

July 21, 2004

By Peter O'Donnell

EU Platform To Add Biotech's Benefits To Chemical Industry

July 14, 2004

By Peter O'Donnell

EU Platform To Add Biotech's Benefits To Chemical Industry

July 14, 2004

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...